Longboard Pharmaceuticals Inc (LBPH) PT Raised to $42 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/4/2026
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Broadcom's sales and AI chip forecast comes in below expectations, shares tumble
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Oil gains as Middle East hostilities flare
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
- Navitas showcases 800V power delivery board at NVIDIA MGX ecosystem event
- Inotiv files for bankruptcy with $65 million financing commitment
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
- After-Hours Stock Movers: PANW, CRWD, ZS, GTLB, ULTA
- After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- After-Hours Stock Movers: DELL, MDB, AEO, NTAP, GAP, S, ADSK
- After-Hours Stock Movers: CRM, MRVL, SNOW, HPQ, DDOG, MDB, P, SNPS, BRZE, NCNO
Citi Reiterates Buy Rating on Longboard Pharmaceuticals Inc (LBPH)
June 11, 2024 5:37 AM EDTCiti analyst David Hoang reiterated a Buy rating and $40.00 price target on Longboard Pharmaceuticals Inc (NASDAQ: LBPH).
The analyst comments "LBPH reported a first data cut from the PACIFIC OLE study that supports our thesis for bexicaserin to become a blockbuster product with... More
Longboard Pharmaceuticals Inc (LBPH) PT Raised to $36 at B.Riley
June 10, 2024 4:21 PM EDTB.Riley analyst Kalpit Patel raised the price target on Longboard Pharmaceuticals Inc (NASDAQ: LBPH) to $36.00 (from $30.00) while maintaining a Buy rating.
The analyst comments "On Monday (6/10), Longboard Pharma (LBPHBuy, $36 PT) delivered an update from the open-label extension portion of the PACIFIC... More
